Section of General Pathology, Department of Experimental Medicine, University of Genoa, Genoa, Italy.
Section of Biochemistry, Department of Experimental Medicine, Center for Excellence in Biomedical Research (CEBR), University of Genoa, Genoa, Italy.
Biofactors. 2021 Jan;47(1):126-134. doi: 10.1002/biof.1705. Epub 2021 Jan 19.
Intraneuronal accumulation of hyperphosphorylated tau is a pathological hallmark of several neurodegenerative disorders, including Alzheimer's disease. Phosphorylation plays a crucial role in modulating the tau-microtubule interaction and the ability of the protein to aggregate, but despite efforts during the past decades, the real identity of the kynases involved in vivo remains uncertain. Here, for the first time, we demonstrate that the cGMP-dependent protein kinase G (PKG) phosphorylates tau in both in vitro and in vivo models. More intriguingly, we provide evidence that PKG phosphorylates tau at Ser214 but not at Ser202, a condition that could reduce the pathological aggregation of the protein shifting tau from a pro-aggregant to a neuroprotective anti-aggregant conformation.
神经元内过度磷酸化的 tau 积聚是包括阿尔茨海默病在内的几种神经退行性疾病的病理标志。磷酸化在调节 tau-微管相互作用和蛋白质聚集能力方面起着至关重要的作用,但尽管在过去几十年中做出了努力,体内涉及的激酶的真实身份仍然不确定。在这里,我们首次证明 cGMP 依赖性蛋白激酶 G(PKG)在体外和体内模型中均可使 tau 磷酸化。更有趣的是,我们提供的证据表明,PKG 可使 tau 在 Ser214 而不是 Ser202 处磷酸化,这种情况可以减少蛋白质的病理性聚集,从而将 tau 从促聚集状态转变为具有神经保护作用的抗聚集构象。